Deksalgin is a non-steroidal anti-inflammatory drug, an inhibitor of cyclooxygenase (analgesic).
Deksalgin has analgesic, anti-inflammatory and antipyretic properties. The active ingredient of the drug is a salt of propionic acid - dexketoprofen trometamol.
After oral administration Deksalgin begins to operate within an hour. After the same period of time the maximum observed drug concentration in blood. The therapeutic effect of the drug Deksalgin, reviews confirm maintained for 3-6 hours.
Apply Deksalgin guide recommends that you:
- symptomatic treatment of dental pain;
- painful sensations that accompany menstruation;
- pain syndrome, acute and chronic diseases of the musculoskeletal system.
Instructions for use Deksalgina
Deksalgin whose use does not involve long treatment assigned as needed, usually for a period of 3 to 5 days.
Deksalgin in the form of tablets to be taken every 4-6 hours at 12, 5 mg (Table 1/2.) From 1 to 6 times a day or every 8 hours with 25 mg (1 tab.) Up to three times a day. The daily dose should be in the range of 75 mg (Table 3.). Patients with impaired renal or hepatic function, as well as elderly persons daily dose should not exceed 50 mg.
Deksalgin injections can be administered intravenously and intramuscularly.
Adults are usually administered 50 mg every 8-12 hours. If necessary, re-introduction Deksalgina made 6 hours. The daily dose should not exceed 150 mg. Apply Deksalgin injections should not be longer than 2 days.
The drug Deksalgin reviews describe as well-tolerated drug, but in some cases may be a manifestation of these adverse reactions such as:
- insomnia, dizziness, headache;
- anemia (a decrease in the concentration of hemoglobin), thrombocytopenia (reduced platelet count), neutropenia (decrease in the level of neutrophils);
- blurred vision, ringing in the ears;
- rush of blood to the skin, hot flashes, decrease in blood pressure, heart palpitations, superficial thrombophlebitis (inflammation of the vein wall and thrombus formation);
- decrease in breathing, bronchospasm;
- vomiting, nausea, constipation, diarrhea, indigestion, anorexia, dry mouth, bloody vomiting, erosive and ulcerative lesions of the digestive tract;
- jaundice, elevated liver enzymes;
- renal colic, polyuria (increased urine production), nephritis (inflammation of the kidneys);
- deviations from the normal menstrual cycle (in women), prostate dysfunction (in men);
- shortness of motion in the joints, muscle spasm;
- sweating, rash, dermatitis, urticaria, angioedema,
- hypoglycemia (decrease in blood glucose levels), hyperglycemia (high glucose concentration);
- fatigue, chills, feeling of fever, fainting, back pain, fever;
- Deksalgin after injections - hemorrhage (bleeding due to rupture of the vessel), hematoma, inflammatory reactions at the injection site.
From application Deksalgina should give patients with:
- erosive and ulcerative lesions of the gastrointestinal tract;
- severely impaired liver or kidney function;
- hemorrhagic diathesis;
- severe heart failure;
- hypersensitivity to the drug.
According to the instructions, Deksalgin contraindicated in children, pregnant and lactating women, as well as patients taking drugs that prevent the formation of blood clots and blood clotting (anticoagulants).
Deksalgin Tablets should be stored away from light at a temperature not exceeding 30
The drug as a solution for injection should be stored in a place where the temperature does not rise above 25
C. A dilute solution is considered suitable for use during a day under the condition of storage in a cool and dark (2-8
C) place. Shelf life Tablets Deksalgin - 2 years, ampoule solution - 5 years.